Do Differences in Repeat Revascularization Explain the Antianginal Benefits of Bypass Surgery Versus Percutaneous Coronary Intervention?: Implications for Future Treatment Comparisons

@article{Arnold2012DoDI,
  title={Do Differences in Repeat Revascularization Explain the Antianginal Benefits of Bypass Surgery Versus Percutaneous Coronary Intervention?: Implications for Future Treatment Comparisons},
  author={Suzanne V. Arnold and Elizabeth A. Magnuson and Kaijun Wang and Patrick Wjc Serruys and Arie Pieter Kappetein and Friedrich W. Mohr and David J. Cohen},
  journal={Circulation: Cardiovascular Quality and Outcomes},
  year={2012},
  volume={5},
  pages={267–275}
}
Background— Patients with multivessel coronary disease treated with coronary artery bypass graft (CABG) have less angina than those treated with percutaneous coronary intervention (PCI); however, there is uncertainty as to the mechanism of greater angina relief with CABG and whether more frequent repeat revascularization in patients treated with PCI could account for this treatment difference. Methods and Results— In the Synergy between percutaneous coronary intervention (PCI) with TAXUS and… Expand
Mortality After Repeat Revascularization Following PCI or Coronary Artery Bypass Grafting for Left Main Disease: The EXCEL Trial.
TLDR
In the EXCEL trial, repeat revascularization during follow-up was performed less frequently after CABG than PCI and was associated with increased mortality after both procedures, which may further improve long-term survival after percutaneous or surgical treatment of LMCAD. Expand
Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.
TLDR
For patients with diabetes and multivessel CAD, CABG surgery provided slightly better intermediate-term health status and quality of life than PCI using drug-eluting stents. Expand
Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention: what do the trials tell us?
  • A. Kulik
  • Medicine
  • Current opinion in cardiology
  • 2017
TLDR
Patients with multivessel coronary artery disease attain important QOL benefits following revascularization with either PCI or CABG, and significant benefits remain favoring CabG in term of physical, emotional, and mental health. Expand
Coronary Artery Bypass Grafting or Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease
TLDR
In diabetic patients with multivessel coronary artery disease, CABG was associated with a lower rate of major adverse cardiovascular and cerebrovascular events compared with FFR-guided PCI, driven by a higher rate of repeat revascularization. Expand
Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease
Fro Im Ce ter Ne Ho U Sy ISS OBJECTIVES The aim of this study was to investigate the incidence and impact on mortality of repeat revascularization after index percutaneous coronary intervention (PCI)Expand
Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
TLDR
Findings suggest that PCI and CABG provide similar intermediate-term outcomes for patients with LMCAD, although a greater early benefit is seen with PCI. Expand
Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
TLDR
Among patients with 3-vessel or left main CAD, both CABG and DES-PCI were associated with substantial and sustained quality-of-life benefits over 5 years of follow-up, reinforcing the recommendation that CabG should be strongly preferred for such patients. Expand
Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
OBJECTIVES The study sought to determine the incidence, predictors, characteristics, and outcomes of repeat revascularization during 5-year follow-up of the SYNTAX (Synergy Between PercutaneousExpand
Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease
TLDR
Findings suggest that PCI and CABG provide similar intermediate-term outcomes for patients with LMCAD, although a greater early benefit is seen with PCI. Expand
Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease: a five-year registry study
TLDR
Investigation of the long-term relationship between revascularization technique and health status in diabetics with multivessel disease finds benefits were attenuated at 3-years and majority of domains were similar at 5-years. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 23 REFERENCES
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.
TLDR
Among patients with three-vessel or left main coronary artery disease, there was greater relief from angina after CABG than after PCI at 6 and 12 months, although the extent of the benefit was small. Expand
Disease-Specific Health Status After Stent-Assisted Percutaneous Coronary Intervention and Coronary Artery Bypass Surgery: One-Year Results From the Stent or Surgery Trial
TLDR
During the first postprocedure year, patients’ angina burden and physical limitations were alleviated to a greater extent with CABG and stent-assisted PCI dramatically improved cardiac-related health status in patients with multivessel disease at 6- and 12-month follow-up. Expand
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
TLDR
CABG remains the standard of care for patients with three-vessel or left main coronary artery disease, since the use of CABG, as compared with PCI, resulted in lower rates of the combined end point of major adverse cardiac or cerebrovascular events at 1 year. Expand
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.
TLDR
As measured one year after the procedure, coronary stenting for multivessel disease is less expensive than bypass surgery and offers the same degree of protection against death, stroke, and myocardial infarction, however, stenting is associated with a greater need for repeated revascularization. Expand
A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass.
TLDR
Over 12 months of follow-up, health status was improved to a greater extent for CABG patients than for PCI patients, primarily due to the adverse influence of restenosis after PCI. Expand
Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI).
TLDR
In this one-year angiographic substudy of BARI, CABG provided more complete revascularization than PTCA, andCABG likewise improved angina to a greater extent than P TCA. Expand
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.
TLDR
This study will define the roles of CABG and PCI using drug-eluting stents in the contemporary management of LM and 3VD by replacing most traditional inclusion and exclusion criteria with the real-world decision between the cardiothoracic surgeon and the interventionalist. Expand
Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis
TLDR
In the early 1970s, coronary artery bypass graft (CABG) was found to improve late survival in comparison to medical therapy in patients with significant left main stenosis, and the introduction of drug-eluting stents (DES) raised the possibility of improved late outcomes in this challenging patient group. Expand
Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial.
TLDR
In patients undergoing revascularization for AMI, initial stent placement is associated with improvements in several dimensions of health status during the first six months of follow-up, adding to the overall argument in favor of initial stenting in patients treated with mechanical reperfusion for myocardial infarction. Expand
First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants.
  • Medicine
  • Lancet
  • 1995
TLDR
The findings of CABRI are consistent with previous studies, and add to the weight of information that clinicians need to discuss with patients when options for the management of severe angina are under consideration. Expand
...
1
2
3
...